EP 1504026 A4 20051221 - THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODINGS SAME, AND METHODS OF USE
Title (en)
THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODINGS SAME, AND METHODS OF USE
Title (de)
THERAPEUTISCHE POLYPEPTIDE, DIESE CODIERENDE NUKLEINSÄUREN UND VERWENDUNGSVERFAHREN
Title (fr)
POLYPEPTIDES THERAPEUTIQUES, ACIDES NUCLEIQUES CODANT CEUX-CI ET PROCEDES D'UTILISATION
Publication
Application
Priority
- US 0238594 W 20021203
- US 33660001 P 20011205
- US 33828501 P 20011207
- US 34134601 P 20011212
- US 34154001 P 20011217
- US 34147701 P 20011217
- US 34259201 P 20011220
- US 34429701 P 20011227
- US 34490301 P 20011231
- US 37328802 P 20020417
- US 38098102 P 20020515
- US 38149502 P 20020517
- US 38374402 P 20020528
- US 38353402 P 20020528
- US 38382902 P 20020529
- US 38402402 P 20020529
- US 40178802 P 20020807
- US 40635302 P 20020826
- US 42275602 P 20021031
- US 30929002 A 20021202
Abstract (en)
[origin: WO03050245A2] Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same are also included. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
IPC 1-7
IPC 8 full level
C07K 1/00 (2006.01); C07K 14/47 (2006.01); C07K 14/81 (2006.01); C12N 9/00 (2006.01); A61K 38/00 (2006.01); A61K 48/00 (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); A61P 3/00 (2017.12); A61P 3/04 (2017.12); A61P 3/06 (2017.12); A61P 3/10 (2017.12); A61P 7/02 (2017.12); A61P 7/04 (2017.12); A61P 9/00 (2017.12); A61P 9/04 (2017.12); A61P 9/10 (2017.12); A61P 9/12 (2017.12); A61P 11/06 (2017.12); A61P 15/00 (2017.12); A61P 17/00 (2017.12); A61P 19/00 (2017.12); A61P 25/00 (2017.12); A61P 25/16 (2017.12); A61P 25/28 (2017.12); A61P 31/00 (2017.12); A61P 31/18 (2017.12); A61P 35/00 (2017.12); A61P 37/02 (2017.12); A61P 37/06 (2017.12); A61P 43/00 (2017.12); C07K 14/47 (2013.01); C12N 9/00 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
- [XD] WO 0159155 A2 20010816 - PHARMA PACIFIC PTY LTD [AU], et al
- [X] WO 9907740 A2 19990218 - ZYMOGENETICS INC [US]
- [X] DATABASE EMBL [online] 14 January 1992 (1992-01-14), "Homo sapiens mRNA for von Ebner's gland protein", XP002335191, retrieved from EBI accession no. EM_PRO:HSVEGP Database accession no. HSVEGP
- See references of WO 03050245A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SI SK TR
DOCDB simple family (publication)
WO 03050245 A2 20030619; WO 03050245 A3 20041216; WO 03050245 A8 20040513; AU 2002359579 A1 20030623; CA 2467721 A1 20030619; EP 1504026 A2 20050209; EP 1504026 A4 20051221; JP 2006507793 A 20060309
DOCDB simple family (application)
US 0238594 W 20021203; AU 2002359579 A 20021203; CA 2467721 A 20021203; EP 02794126 A 20021203; JP 2003551267 A 20021203